Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 6/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | STS | P08842 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22465827 | 1.00 | HSD17B3 (0.44) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL22465842 | 1.00 | HSD17B3 (0.44) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL19457999 | 0.84 | HSD17B3 (0.55) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL19458018 | 0.84 | HSD17B3 (0.55) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL19458032 | 0.82 | HSD17B3 (0.53) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL22680801 | 0.81 | ALDH1A1 (0.45) | HSD17B3HTTMEN1ALDH1A1MAPT | |
| SCHEMBL7753632 | 0.80 | HTT (0.35) | HSD17B3HTTMEN1ALDH1A1KMT2A | |
| SCHEMBL8476172 | 0.79 | HPGD (0.66) | HTTALDH1A1HPGDCA2 | |
| SCHEMBL8478721 | 0.79 | HPGD (0.66) | HTTALDH1A1HPGDCA2 | |
| SCHEMBL8474666 | 0.78 | HPGD (0.63) | HTTALDH1A1HPGDCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11149188-B2 | Oleofuransulfonate surfactants for use in wellbore applications | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-10-19 | — | — | US | claimed |
| US-20200308475-A1 | OLEOFURANSULFONATE SURFACTANTS FOR USE IN WELLBORE APPLICATIONS | HALLIBURTON ENERGY SERVICES, INC. | 2020-10-01 | — | — | US | claimed |
| US-11149188-B2 | Oleofuransulfonate surfactants for use in wellbore applications | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-10-19 | — | — | US | disclosed |
| US-20200308475-A1 | OLEOFURANSULFONATE SURFACTANTS FOR USE IN WELLBORE APPLICATIONS | HALLIBURTON ENERGY SERVICES, INC. | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11149188-B2 | Oleofuransulfonate surfactants for use in wellbore applications | VAPB, OSBP, STOM | HSD17B3 1449/4885HTT 2687/4885MEN1 4273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.